Implementation Science Center for Cancer Control Equity
The Implementation Science Center for Cancer Control Equity (ISCCCE) is one of seven such centers funded by the National Cancer Institute Moonshot Initiative. ISCCCE aims to develop sustainable strategies for ensuring that all patients have access to evidence-based cancer prevention and control.
ISC3 Consortium
The Implementation Science Centers in Cancer Control (ISC3) Program supports the rapid development, testing, and refinement of innovative approaches to implement a range of evidence-based cancer control interventions. ISCCCE is one of seven centers funded by the National Cancer Institute’s Cancer Moonshot initiative, which collectively provides leadership for an Implementation Science consortium across Cancer Moonshot initiatives.
The Implementation Science Center for Cancer Control Equity (ISCCCE) at Harvard is improving community health by integrating health equity and implementation science for evidence-based cancer control.
MPI: Karen Emmons & Elsie Taveras
The Building Research in Implementation and Dissemination to close Gaps and Achieve Equity in Cancer Control (BRIDGE-C2) Center will focus on advancing implementation science to improve cancer screening and prevention in underserved populations.
PI: Jennifer DeVoe
Colorado ISC3 will focus on pragmatic approaches to assess and enhance the value of cancer prevention and control in rural primary care.
PI: Russell Glasgow
The Optimizing Implementation in Cancer Control (OPTICC) Center will develop, test, and refine innovative methods for optimizing the implementation of evidence-based interventions in cancer control.
MPI: Bryan Weiner, Margaret Hannon, & Cara Lewis
Implementation and Informatics – Developing Adaptable Processes and Technologies for Cancer Control (iDAPT) will advance the field of implementation science by using technologies to support rapid cycle and real-time deployment and testing of implementation processes and adaptations within cancer control.
MPI: Kristie Long Foley, Thomas Houston, & Sarah Cutrona
The WU-ISCCC will build a rigorous, scientific evidence base for rapid-cycle implementation research to increase the reach, external validity, and sustainability of effective cancer control interventions. The Center’s goal and activities capture three distinct features: (1) a focus on elimination of cancer disparities; (2) the need for rapid-cycle studies; and (3) the use of systems science approaches to enhance methods and outcomes in implementation science.
MPI: Ross Brownson & Graham Colditz
The Penn ISC3 will apply insights from behavioral economics to rapidly accelerate the pace at which evidence-based practices for cancer care are deployed and to which they are delivered equitably, thereby increasing their reach and impact on the health of individuals with cancer.
MPI: Justin Bekelman, Rinad Beidas, & Robert Schnoll